Simultaneous Determination Of Alpha-Fetoprotein And Free Beta-Human Chorionic Gonadotropin By Element-Tagged Immunoassay With Detection By Inductively Coupled Plasma Mass Spectrometry
Sichun Zhang,Chao Zhang,Zhi Xing,Xinrong Zhang
DOI: https://doi.org/10.1373/clinchem.2003.029850
IF: 12.114
2004-01-01
Clinical Chemistry
Abstract:Background: An inductively coupled plasma mass spectrometry (ICP-MS)-based immunoassay has been proposed independently by Baranov et al. (Anal Chem 2002;74:1629-36) and our group, but the applicability of this method for multianalyte analysis in clinical samples has not been fully illustrated. We developed a dual-label immunoassay method for the simultaneous determination of alpha-fetoprotein (AFP) and free beta-human chorionic gonadotropin (hCGbeta) in human serum.Methods: Monoclonal antibodies immobilized on microtiter plates captured AFP and hCGbeta, which were detected by use of Eu3+-labeled anti-AFP and Sm3+-labeled anti-hCGbeta monoclonal antibodies. Eu3+ and Sm3+ were dissociated from the immunocomplex with HNO3 solution (10 mL/L) and delivered by peristaltic pump to the ICP mass spectrometer.Results: The measurable ranges of AFP and hCGbeta were 4.6-500 and 5.0-170 mug/L, respectively, with detection limits of 1.2 and 1.7 mug/L (3 SD above mean of zero calibrator), respectively. The intraassay imprecision (CV) for AFP was 8.3%, 4.0%, and 2.7% at 16.3, 86, and 354 mug/L, respectively, and the interassay CV was 10%, 5.7%, and 3.5%. For hCGbeta, the intraassay CV was 5.4%, 6.4%, and 3.1%, respectively, at 10.5, 45.2, and 105 mug/L, and the interassay CV was 7.2%, 8.0%, and 3.7%. Comparison with IRMAs for AFP and hCGbeta yielded correlation coefficients (r(2)) of 0.97 and 0.95.Conclusions: Two proteins can be measured simultaneously by immunoassays using two rare earth elemental tags (Eu3+ and Sm3+) and ICP-MS detection. The multielement capability and the multiple potential elemental labels make ICP-MS attractive for multianalyte immunoassays. Implementation of ICP-MS-linked immunoassays may be relatively straightforward because the labeling and immunoreaction procedures have been well developed for clinical time-resolved immunofluorometric assays. (C) 2004 American Association for Clinical Chemistry.